LabCompass

Li‐Fan Zeng

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Protein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancerGalectins and Cancer BiologyHIV Research and TreatmentHIV/AIDS drug development and treatment

Publications

67

Citations

1,783

Est. group size

—

Recurring co-author estimate

Active years

31

Publishing since 1995

Research summary
AI-generated

Li-Fan Zeng's research focuses largely on protein tyrosine phosphatases—enzymes such as SHP2 and PRL that regulate cell signaling—and how inhibiting them might treat diseases including cancer, melanoma, lupus, and rheumatoid arthritis. More recent work explores neuroinflammation and interferon-related genes in Alzheimer's disease, along with some publications on materials chemistry for redox flow batteries.

Protein tyrosine phosphatases (SHP2, PRL) as drug targetsAnticancer agent developmentAutoimmune and inflammatory disease mechanismsNeuroinflammation and Alzheimer's diseaseRedox flow battery chemistry

Publication activity was concentrated around 2016-2017, dropped for several years, then rose again with a peak in 2023, indicating renewed and somewhat variable output in recent years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.4/year recently
2017: 5 publications172018: 1 publication1819202021: 1 publication212022: 2 publications222023: 8 publications8232024: 3 publications242025: 4 publications2526
Recent publications
Publishes in
  • PMC×4
  • bioRxiv (Cold Spring Harbor Laboratory)×3
  • Oncotarget×2
  • SSRN Electronic Journal×2
  • Molecular Therapy — Methods & Clinical Development×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile